HPa2 Monoclonal Antibody Supernatant from Hybridoma DHIC2-2B4 (alpha cell marker)

Technology Overview

The monoclonal antibody HPa2 is derived from the hybridoma DHIC2-2B4.  HPa2 selectively reacts with a cell surface module on human pancreatic endocrine cells. This antibody reacts with multiple endocrine cell types.
 

Antibody: HPa2 Supernatant
Hybridoma cell line: DHIC2-2B4
Isotype: Mouse IgM
Species reactivity: Human
Applications: Immunohistochemistry (acetone fixation recommended), Flow cytometry
Availability:  1mL supernatant aliquot.

 
Patent Information:
Direct Link:
https://canberra-ip.technologypublisher.com/tech/HPa2_Monoclonal_Antibody_Sup ernatant_from_Hybridoma_DHIC2-2B4_(alpha_cell_marker)
Keywords:
Bookmark this page
For Information, Contact:
Cadence True
Technology Collaboration Manager
Oregon Health & Science University
trueca@ohsu.edu